Patent · US Active

Cyclized derivatives as Eg-5 inhibitors

US7820646B2 · kind B2 · utility

0Cited by

12References

20Claims

0Family size

Assignee

Novartis Vaccines and Diagnostics, Inc. · US

Inventors

Rustum Boyce · San Francisco, US
Eric Martin · Corona, US
Weibo Wang · Moraga, US
Hong Yang · Foster City, US
Paul A. Barsanti · Emeryville, US

Key dates

Filing date	Jan 3, 2008
Grant date	Oct 26, 2010
Priority date	—
Expiry date	Feb 28, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.